Further to Drug Alert EL (20)A/52 issued on 11 November 2020, medac Pharma LLP is recalling further batches of products following inspection of vials showing hairline damage to the shoulder of the vials. So far, the company has not received any reports of damage for marketed products. However, as this defect may impact on the sterility of the product, specified batches are being recalled as a precautionary measure. This is a second alert for further batches identified.
Further information and details of the affected batches can be found on the MHRA website.